FIELD: medicine.
SUBSTANCE: methods for the treatment of a subject, who needs the treatment of a complement-mediated disorder, are proposed, including the administration of a long-acting compstatin analogue (hereinafter – LACA) containing PEG with an average molecular weight of 40 kDa, subcutaneously at a dose of 1080 mg. A single dosed composition of LACA containing PEG with an average molecular weight of 40 kDa is proposed for the treatment of a complement-mediated disorder in a subject for subcutaneous administration in the amount of 1080 mg. A device is proposed for delivery of a drug containing the specified single dosed composition.
EFFECT: proposed group of inventions provides for increase in doses of a long-acting compstatin analogue containing 40 kDa of PEG.
27 cl, 28 dwg, 23 tbl, 30 ex
| Title |
Year |
Author |
Number |
| INJECTION SCHEMES |
2016 |
- Grossi, Federiko
- Deshatelets, Paskal
- Fransua, Sedrik
|
RU2770099C2 |
| CELL-REACTIVE COMPOSTATIN ANALOGUES, LONG-ACTING COMPSTATIN ANALOGUES OR COMPUTED EFFECT ANALOGUES OF TARGETED ACTION AND RELATED COMPOSITIONS AND METHODS |
2013 |
- Fransua Sedrik
- Deshatele Paskal
|
RU2705215C2 |
| CELL-REACTIVE COMPSTATIN ANALOGS, LONG-ACTING COMPSTATIN ANALOGS, OR TARGETED COMPSTATIN ANALOGS AND USES THEREOF |
2012 |
- Fransua Sedrik
- Deshatele Paskal
|
RU2653439C9 |
| PROLONGED DELIVERY OF COMPSTATIN ANALOGUES FROM GELS |
2008 |
- Fransua Sedrik
- Deshatelets Paskal'
- Olson Pol
|
RU2505311C2 |
| GIP AGONIST COMPOUNDS AND METHODS |
2015 |
- Shelton Pernilla Tofteng
- Norregaard Pia
- Deryabina Mariya Aleksandrovna
- Larsen Byarn Dyu
- Fog Dzhejkob Ulrik
|
RU2716985C2 |
| PEPTIDES AND PEPTIDOMIMETICS FOR COMBINED USE AND TREATMENT IN A SUBPOPULATION OF PATIENTS WITH CANCER DISEASES |
2014 |
- Kavabe Takumi
- Mine Naoki
- Saito Naoya
- Sakakibara Kejiti
- Sato Takudzi
|
RU2732440C2 |
| PEPTIDE HAVING ACTIVITY OF HUMAN SLURP-1 PROTEIN AND ITS APPLICATION FOR SUPPRESSION OF GROWTH OF CARCINOMA AND GLIOMA, PHARMACEUTICAL COMPOSITION FOR SUPPRESSION OF GROWTH OF CARCINOMA AND GLIOMA, AND METHOD FOR SUPPRESSION OF GROWTH OF CARCINOMA AND GLIOMA USING THE SPECIFIED PEPTIDE |
2022 |
- Lyukmanova Ekaterina Nazymovna
- Shenkarev Zakhar Olegovich
- Shulepko Mikhail Anatolevich
- Bychkov Maksim Leonidovich
- Kulbatskii Dmitrii Sergeevich
- Kirpichnikov Mikhail Petrovich
|
RU2792364C1 |
| PEPTIDE ANALOG OF ACYLATED OXYNTOMODULIN |
2018 |
- Che, Iu-Na
- Li, Kajung-Seok
- Che, Yu-Na
- Baek, Gaje-Rim
- Kim, Tae-Khajong
- Yung, Ill-Khun
- Ryu, Che-Lim
- Im, Veon-Bin
|
RU2752787C1 |
| PEPTIDE HAVING LYNX1 PROTEIN ACTIVITY (EMBODIMENTS), PHARMACEUTICAL COMPOSITION FOR TREATING ANXIETY DISORDERS AND DEPRESSION OR CORRECTION OF COGNITIVE DISORDERS IN NEURODEGENERATIVE DISEASES, CONTAINING SAID PEPTIDE, AND METHOD OF TREATING AND CORRECTING SAID DISORDERS |
2020 |
- Kirpichnikov Mikhail Petrovich
- Lyukmanova Ekaterina Nazymovna
- Shenkarev Zakhar Olegovich
- Shulepko Mikhail Anatolevich
|
RU2734649C1 |
| ANTIBODIES SUITABLE FOR PASSIVE IMMUNIZATION AGAINST INFLUENZA, AND COMPOSITIONS THEREOF, COMBINATIONS AND METHODS OF USING |
2015 |
- Estelles Andzheles
- Kauvar Lourens M.
- Vigil Adam
- Vittekind Majkl
|
RU2720282C1 |
